1. Mutations in chronic myelomonocytic leukemia and their prognostic relevance

   • J. Jian
   • Y. Qiao
   • B. Liu

   Review Article 16 April 2021 Pages: 1731 - 1742

   

2. CDK1 promotes the stemness of lung cancer cells through interacting with Sox2

   • Z. Huang
   • G. Shen
   • J. Gao

   Research Article 15 March 2021 Pages: 1743 - 1751

   

3. Urologic, lymphedema, pelvic pain and gastrointestinal symptoms increase after radiotherapy in patients with primary uterine tumors: a prospective longitudinal Swedish cohort study

   • A. Holmqvist
   • A. Axelsson
   • S. Uppugunduri

   Research Article Open access 08 March 2021 Pages: 1752 - 1760

   

4. Validation and comparison of Breast Graded Prognostic Assessment scores in patients with breast cancer and brain metastases

   • C. Fabregat-Franco
   • A. Stradella
   • M. J. Gil-Gil

   Research Article 11 March 2021 Pages: 1761 - 1768

   

5. A comprehensive analysis of tumor microenvironment-related genes in colon cancer

   • R. Luo
   • W. Guo
   • H. Wang

   Research Article 10 March 2021 Pages: 1769 - 1781

   

6. Investigation on potential biomarkers of hyperprogressive disease (HPD) triggered by immune checkpoint inhibitors (ICIs)

   • J. Liu
   • Q. Wu
   • X. Xie

   Research Article 13 April 2021 Pages: 1782 - 1793

   

7. SEOR SBRT-SG survey on SRS/SBRT dose prescription criteria in Spain

   • M. J. Perez-Calatayud
   • A. J. Conde-Moreno
   • J. Perez-Calatayud

   Research Article 17 March 2021 Pages: 1794 - 1800

8. Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment

   • A. Lozano
   • J. Marruecos
   • R. Mesía

   Research Article 18 March 2021 Pages: 1801 - 1810

   

9. Suppression of MD2 inhibits breast cancer in vitro and in vivo

   • S. Zheng
   • W. Fu
   • G. Guo

   Research Article Open access 17 March 2021 Pages: 1811 - 1817

   

10. Upfront pembrolizumab as an effective treatment start in patients with PD-L1 ≥ 50% non-oncogene addicted non-small cell lung cancer and asymptomatic brain metastases: an exploratory analysis

    • G. Metro
    • A. Gili
    • F. Roila

    Research Article 16 March 2021 Pages: 1818 - 1826

    

11. PARP inhibitor niraparib as a radiosensitizer promotes antitumor immunity of radiotherapy in EGFR-mutated non-small cell lung cancer

    • N. Zhang
    • Y. Gao
    • C. Xie

    Research Article 28 March 2021 Pages: 1827 - 1837

    

12. Prognostic factors in advanced pancreatic ductal adenocarcinoma patients-receiving second-line treatment: a single institution experience

    • L. Gutierrez-Sainz
    • D. Viñal
    • J. Feliu

    Research Article 17 April 2021 Pages: 1838 - 1846

    

13. Medical ozone induces proliferation and migration inhibition through ROS accumulation and PI3K/AKT/NF-κB suppression in human liver cancer cells in vitro

    • J. Li
    • T. Zeng
    • X. He

    Research Article 05 April 2021 Pages: 1847 - 1856

    

14. Extended intraoperative peritoneal lavage as prophylactic peritoneal recurrence for locally advanced gastric cancer: a prospective randomized trial

    • J. Rodríguez-Santiago
    • A. Luna
    • A. Rada

    Research Article 01 April 2021 Pages: 1857 - 1865

    

15. Propofol inhibited gastric cancer proliferation via the hsa-miR-328-3p/STAT3 pathway

    • Z. M. Bai
    • X. F. Li
    • L. L. Tang

    Research Article 27 March 2021 Pages: 1866 - 1873

    

16. Association of TYRP1 with hypoxia and its correlation with patient outcome in uveal melanoma

    • J. Jha
    • M. K. Singh
    • S. Kashyap

    Research Article 03 April 2021 Pages: 1874 - 1884

    

17. Systematic review and meta-analysis efficacy and safety of immune checkpoint inhibitors in advanced melanoma patients with anti-PD-1 progression: a systematic review and meta-analysis

    • N. N. Alrabadi
    • H. M. Abushukair
    • F. A. Al Qarqaz

    Research Article 20 April 2021 Pages: 1885 - 1904

    

18. Circ_03955 promotes pancreatic cancer tumorigenesis and Warburg effect by targeting the miR-3662/HIF-1α axis

    • A. Liu
    • J. Xu

    Research Article 17 April 2021 Pages: 1905 - 1914

    

19. Synchronous bilateral breast cancer treated with a 3-week hypofractionated radiotherapy schedule: clinical and dosimetric outcomes

    • J. Gadea
    • I. Ortiz
    • J. Pardo

    Research Article 08 April 2021 Pages: 1915 - 1922

    

20. Tumor microenvironment-associated gene C3 can predict the prognosis of colorectal adenocarcinoma: a study based on TCGA

    • Y. Liu
    • X. Wang

    Research Article 25 March 2021 Pages: 1923 - 1933

    

21. Intraoperative electron beam radiotherapy and perioperative high-dose-rate brachytherapy in previously irradiated oligorecurrent gynecological cancer: clinical outcome analysis

    • P. A. Jablonska
    • M. Cambeiro
    • R. Martínez-Monge

    Research Article 09 April 2021 Pages: 1934 - 1941

    

22. A novel tumor suppressor CECR2 down regulation links glutamine metabolism contributes tumor growth in laryngeal squamous cell carcinoma

    • Xiaoting Wang
    • Chong Xu
    • Feng Liu

    Research Article 07 April 2021 Pages: 1942 - 1954

    

23. Social support, coping strategies and sociodemographic factors in women with breast cancer

    • C. Calderon
    • D. Gomez
    • P. Jimenez-Fonseca

    Brief Research Article 10 April 2021 Pages: 1955 - 1960

24. Immune checkpoint inhibitors and pre-existing antinuclear antibodies: the rheumatologist point of view

    • F. Ceccarelli
    • A. Botticelli
    • F. Conti

    Correspondence 17 March 2021 Pages: 1961 - 1962

25. Blinatumomab to improve the outcome of children with relapsed B-cell acute lymphoblastic leukemia

    • J. L. Fuster
    • F. Bautista
    • the Leukemia Working Group of the Spanish Society of Pediatric Hematology and Oncology (SEHOP)

    Correspondence 19 March 2021 Pages: 1963 - 1966